Vasundhara Rasayans
169.05
-5.95(-3.40%)
Market Cap₹53.71 Cr
PE Ratio9.60
IndustryHealthcare
Company Performance:
1D-3.40%
1M+0.81%
6M+10.24%
1Y-17.21%
5Y+45.73%
View Company Insightsright
More news about Vasundhara Rasayans
06Sept 25
Vasundhara Rasayans Declares Rs. 2 Per Share Dividend, Appoints New Directors
Vasundhara Rasayans Limited has announced a dividend of Rs. 2.00 per equity share. The company appointed Shri Ashok Kumar Jain as Additional Independent Director and Shri Kodakandla Sidarsanam as additional Whole-time Director. The 37th Annual General Meeting (AGM) is scheduled with book closure from September 24-30 and a cut-off date of September 23 for e-voting and dividend eligibility. Mrs. Rakhi Agarwal has been appointed as the e-voting Scrutinizer for the AGM.
 no imag found
13Aug 25
Vasundhara Rasayans Reports Q1 Net Profit of ₹57.28 Crore, Down 33.5% Year-on-Year
Vasundhara Rasayans Limited announced Q1 financial results, showing a 2.08% increase in total income to ₹824.50 lakh, but a 33.51% decrease in net profit to ₹57.28 lakh. Net sales slightly decreased by 0.90% to ₹756.15 lakh. Total expenses rose by 8.08% to ₹747.10 lakh, primarily due to increased finance costs and other expenses. Earnings per share dropped from ₹2.71 to ₹1.80. The company operates in the agri products segment.
 no imag found
Vasundhara Rasayans
169.05
-5.95
(-3.40%)
1 Year Returns:-17.21%
Industry Peers
Sun Pharmaceutical
1,933.50
(+0.63%)
Divis Laboratories
7,066.00
(+1.84%)
Torrent Pharmaceuticals
4,994.00
(+0.87%)
Cipla
1,450.90
(+1.70%)
Zydus Life Science
1,150.60
(+1.71%)
Lupin
2,493.90
(+0.05%)
Mankind Pharma
2,521.50
(+0.56%)
Dr Reddys Laboratories
1,243.00
(+0.69%)
Aurobindo Pharma
1,568.00
(+1.21%)
Laurus Labs
1,568.70
(+0.65%)